Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Fred Hutchinson Cancer Center
Use of glucosamine and chondroitin have been associated with reduced cancer and overall mortality. The aim of this study is to determine whether a common starting dose of glucosamine and chondroitin (1500 mg/d + 1200 mg/d, respectively) reduces systemic inflammation as reflected by a reduction in high sensitivity C-reactive protein.
Age
20–55
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Healthy
Overweight (body mass index kg/m2 (BMI) between 25 and 32.5)
Non-smoking men and women
Aged 20-55y
You may not be if
Chronic medical illness, history of gastrointestinal, hepatic, or renal disorders, or inflammatory conditions (including autoimmune and inflammatory diseases)
Pregnancy or lactation
Currently on a weight-loss diet
BMI (body mass index) \< 25 or \> 30
Alcohol intake of greater than 2 drinks/day
Current use of prescription or over-the-counter medications, (Excluding oral contraceptives and hormone-secreting IUDs), including use of aspirin or NSAIDs more than 2 days per week
Abnormal renal, liver or metabolic test
Inability to swallow pills
Known allergy to shellfish
Not willing to take pills made from shellfish or animal sources
Intention to relocate out of study area within next 4 months
